A Study in Patients With Chronic Obstructive Pulmonary Disease
NCT01245569
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
373
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG:
Foster® 100/6 µg/unit dose
DRUG:
Seretide Accuhaler® 500/50 µg/actuation
Sponsor
Chiesi Farmaceutici S.p.A.